After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...
A 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in ...
Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney ...
According to the World Health Organisation, cardiovascular diseases claim almost 20 million lives every year and remain the leading cause of death ...
The Hearty Soul on MSN
9+ things you didn't know your Apple Watch could do
Discover 9+ Apple Watch hidden features most people never use, from FDA-cleared ECG and sleep apnea detection to fall ...
July 1, 2026 expert reaction to study looking at blood pressure and cholesterol levels in adults with obesity versus in adults with normal BMI . A study published in The Lancet lo ...
Objective Recent advances in giant cell arteritis (GCA) management aim to reduce glucocorticoid (GC). We described changes in ...
In the field of cardiac electrophysiology, atrial fibrillation (AF) poses a significant risk for ischemic stroke, heart failure, and increased mortality.
The US has revised testosterone therapy labels, removing age-related safety warnings based on new clinical evidence, ...
Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease worldwide, applauds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results